The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.

The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructs.

The ability of IL-2 stimulated mononuclear cells to kill the human glioblastoma cell line U251 has been investigated. Highest cytotoxic activity was generated in low cell density cultures incubated for 15 days with 250-1000 U/ml IL-2. Sub-optimal killing was noted, with cells only exposed to IL-2 fo...

Bibliografski detalji
Glavni autori:	Obukhov, S, Gennie, M, Tutt, A, Kemshead, J, Coakham, H, Beverely, P
Format:	Journal article
Jezik:	English
Izdano:	1992

Slični predmeti

T cells and lymphokines.
od: Feldmann, M, i dr.
Izdano: (1989)

DETECTION OF SMALL CELL LUNG-CARCINOMA (SCLC) CELLS IN BONE-MARROW USING MONOCLONAL-ANTIBODIES (MOABS)
od: Moss, F, i dr.
Izdano: (1988)

Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
od: Kerr Pauline E, i dr.
Izdano: (2006-11-01)

Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats
od: Noritaka Maeta, i dr.
Izdano: (2019-05-01)

Moab is my washpot /
od: Fry, Stephen, 1957-, author
Izdano: (1997)

Adnotationes in historiam Moab
od: Norbert Mendecki
Izdano: (1994-12-01)

The novel basement membrane antigen of MoAb LH24 - is it collagen VII?
od: Wojnarowska, F, i dr.
Izdano: (1999)

Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.
od: Zanovello, P, i dr.
Izdano: (1992)

Preclinical Evaluation of a Bone-Marrow Autograft Culture Procedure for Generating Lymphokine-Activated Killer Cells in Vitro
od: Hans-Georg Klingemann, i dr.
Izdano: (1992-01-01)

Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis.
od: Zanovello, P, i dr.
Izdano: (1989)

The Moab Design for Digital Object Versioning
od: Richard Anderson
Izdano: (2013-07-01)

Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity.
od: Zanovello, P, i dr.
Izdano: (1989)

3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo
od: Xiaorong Fu, i dr.
Izdano: (2021-03-01)

The Effects of new T cell line derived lymphokines on B cell activation
od: Perpustakaan UGM, i-lib
Izdano: (1995)

Epitope mapping and in silico characterization of interactions between Der p 7 allergen and MoAb WH9.
od: Hsiao-Yun Tai, i dr.
Izdano: (2013-01-01)

Development and characterization of an immobilized lymphokine membrane
od: Horwitz, Joseph I
Izdano: (2016)

PROTECTION ACTIVITY OF T CELL LYMPHOKINES AGAINST INFECTIOUS BURSAL DISEASE IN LAYER PULLETS
od: Mushtaq T. B. Al-Zuhariy
Izdano: (2023-08-01)

Lymphokines and interleukins emerge from the primeval soup.
od: Feldmann, M
Izdano: (1985)

EFFECT OF LYMPHOKINES ON DRUG RESISTANCE OF BREAST TUMOR
od: L. T. Alimkhodzhayeva
Izdano: (2014-09-01)

De Belén a Moab: Rut 1, 1-6
od: José Vilchez
Izdano: (2019-12-01)

The stimulation of the growth of a murine B cell lymphoma (BCL-1) by T. cell-derived lymphokines
od: , HARYANA, Sofia Mubarika
Izdano: (1985)

Adoptive immunotherapy with interleukin-2 and lymphokine-activated killers in patients with malignant neoplasms of the female reproductive system (a review of literature)
od: A. N. Gritsai, i dr.
Izdano: (2015-01-01)

Regulation of lymphokine production in experimental and human chagas' disease
od: Rick L. Tarleton
Izdano: (1988-11-01)

CAMPATH-1 MOAB IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA (ATP)
od: Lim, S, i dr.
Izdano: (1993)

A Wayside Shrine in Northern Moab. Excavations in the Wadi Ath-Thamad
od: P. M. Michele Daviau, i dr.
Izdano: (2019-06-01)

Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
od: Daniele Caracciolo, i dr.
Izdano: (2021-02-01)

Development of BCMA-Targeted Bispecific Natural Killer Cell Engagers for Multiple Myeloma Treatment
od: Minchuan Zhang, i dr.
Izdano: (2024-11-01)

Interaction of rat monoclonal antibodies with human killer cells.
od: Clark, M, i dr.
Izdano: (1985)

Heterogeneity of inhibition of cytolytic T lymphocyte clones by monoclonal anti-Lyt-2/3 antibodies: parallel effects on cytolysis, proliferation and lymphokine secretion.
od: MacDonald, H, i dr.
Izdano: (1982)

Wee over Moab… Een exegese van Jeremia 48:1-10
od: Eric Peels
Izdano: (2019-01-01)

T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
od: Clark, MR, i dr.
Izdano: (1987)

Immunoregulation in human Schistosomiasis by idiotypic interactions and lymphokine-mediated mechanisms
od: D. G. Colley, i dr.
Izdano: (1987-01-01)

INTERACTION OF RAT MONOCLONAL-ANTIBODIES WITH HUMAN KILLER CELLS (K-CELLS)
od: Hale, G, i dr.
Izdano: (1984)

CD4+ T-cell clones from autoimmune thyroid tissue cannot be classified according to their lymphokine production.
od: Grubeck-Loebenstein, B, i dr.
Izdano: (1990)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
od: Christie P. M. Verkleij, i dr.
Izdano: (2021-03-01)

Using T cell lymphokines of hyperimmunized chickens with Salmonella pullorum to protect layer hens against Salmonella pullorum infection
od: Mushtaq T. Al-Zuhariy
Izdano: (2022-12-01)

Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma.
od: Patel, K, i dr.
Izdano: (1989)

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy
od: Shahryar Khoshtinat Nikkhoi, i dr.
Izdano: (2023-01-01)

Monoclonal antibodies against human T lymphocytes label Purkinje neurones of many species.
od: Garson, J, i dr.
Izdano: (1982)

Monoclonal antibody H9/25 reacts with functional subsets of T and B cells: killer, killer precursor and plaque-forming cells.
od: Takei, F, i dr.
Izdano: (1980)